Picture of Optimind Pharma logo

OMND Optimind Pharma Balance Sheet

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Optimind Pharma, fiscal year end - February 29th, CAD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2023
February 28th
2024
February 29th
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:
fx
Final
fx
Final
fx
Final
FinalFinal
Cash
Cash and Equivalents
Cash and Short Term Investments0.010.0070.0010.5520.029
Net Total Accounts Receivable
Net Total Receivables0.1160.159
Prepaid Expenses
Total Other Current Assets
Total Current Assets0.0110.0110.0220.6680.188
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.0950
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Total Assets0.0110.0110.0221.350.238
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities1.060.0880.1880.6250.367
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities1.060.0880.1880.7150.367
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity-1.05-0.077-0.1660.64-0.129
Total Liabilities & Shareholders' Equity0.0110.0110.0221.350.238
Total Common Shares Outstanding